Abstract
Background
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma. A number of studies have examined the role of genetic polymorphisms in the risk of DLBCL, and several variants have been identified as potential susceptibility genes, of those glutathione-S-transferases T1 and M1 (GSTT1 and GSTM1).
Aim of the work
The aim of the current study was to investigate the influence of inherited genetic polymorphisms of GSTM1 and GSTT1 genes on the susceptibility to DLBCL in Egypt.
Methods
Genotyping of the candidate genes was performed for 71 Egyptian DLBCL patients and 100 age- and gender-matched healthy controls by multiplex polymerase chain reaction technique.
Results
The frequencies of GSTT1 null, GSTM1 null, and dual null genotypes among DLBCL patients were 47.9, 52.1, and 23.9 % respectively.
Conclusion
GSTT1 null genotype conferred almost fourfold increased risk of DLBCL (OR = 3.9, 95 % CI = 1.97–7.75), and the risk increased when confined to male patients (OR = 4.4, 95 % CI = 1.57–12.63), while GSTM1 null genotype was not associated with DLBCL risk. Further studies on the functional consequences of GSTT1 and GSTM1 genetic polymorphisms would pave the way to declare their role in the pathogenesis of DLBCL or as possible predictors for response to therapy.
Similar content being viewed by others
References
Abdelhamid T, Samra M, Ramadan H, Mehessin M, Mokhtar N (2011) Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study. J Natl Cancer Inst 23:17–24
Abdou AG, Asaad NY, Abd El-Wahed MM, et al. (2011) The Prognostic Value of Skp2 Expression in Egyptian Diffuse Large B-Cell Lymphoma. Appl Immunohistochem Mol Morphol (Epub ahead of print)
Al Dayel F, Al-Rasheed M, Ibrahim M et al (2008) Polymorphisms of drug-metabolizing enzymes CYP1A1, GSTT and GSTP contribute to the development of diffuse large B-cell lymphoma risk in the Saudi Arabian population. Leuk Lymphoma 49(1):122–129
Bajpai P, Agwrawal D, Tripathi AK (2007) Genetic polymorphism of GSTM1 and T1 and risk to chronic myeloid leukemia. Leuk Res 31(10):1359–1363
Chiu BC, Kolar C, Gapstur SM et al (2005) Association of NAT and GST polymorphisms with non-Hodgkin’s lymphoma. R J Haematol 128:610–615
Cho HJ, Eom H, Kim H et al (2010) Glutathione-S-transferase genotypes influence the risk of chemotherapy-related toxicities and prognosis in Korean patients with diffuse large B-cell lymphoma. Cancer Genet Cytogenet 198:40–46
Coughlin SS, Hall IJ (2002) A review of genetic polymorphisms and prostate cancer risk. Ann Epidemiol 12(3):182–196
De Roose AJ, Gold IS, Wang S et al (2006) Metabolic gene variants and risk of non-Hodgkin’s lymphoma. Cancer Epidemiol Biomarkers Prev 15:1647–1653
Goldman L, Ezzat S, Mokhtar N et al (2009a) Viral and non-viral risk factors for non-Hodgkin’s lymphoma in Egypt: heterogeneity by histological and immunological subtypes. Cancer Causes Control 20(6):981–987
Goldman L, Ezzat S, Mokhtar N et al (2009b) Viral and non-viral risk factors for non-Hodgkin’s lymphoma in Egypt: heterogeneity by histological and immunological subtypes. Cancer Causes Control 20(6):981–998
Gra OA, Glotov AS, Kozhekbaeva Zh et al (2002) Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia. Mol Biol (Mosk) 42(2):214–225
Gra OA, Glotov AS, Nikitin EA et al (2008) Polymorphisms in xenobiotic metabolizing enzymes genes and the risk of chronic lymphocytic leukemia and non-Hodgkin’s lymphomas in adult Russian patients. Am J Hematol 83(4):279–287
Han X, Li Y, Huang J et al (2010) Identification of predictive pathways for non-hodgkin lymphoma prognosis. Cancer Inf 9:281–292
Harris N, Stein H, Coupland S et al (2001) New approaches to lymphoma diagnosis. Am Soc Haematol 1(1):194–220
Ibrahim AM, Abdel Rahman HA, Khorshied MM, Sami R, Nasr NM, Khorshid OM (2011) Tumor necrosis factor alpha− 308 and Lymphotoxin alpha+ 252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt. Leuk Res [Epub ahead of print]
Kelemen LE, Cerhan JR, Lim U, Davis S, Cozen W et al (2006) Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute—surveillance, epidemiology, and end results population-based case-control study. Am J Clin Nutr 83:1401–1410
Kerridge I, Lincz L, Scorgie F et al (2002) Association between xenobiotic gene polymorphisms and non-Hodgkin’s lymphoma risk. Br J Haematol 118:477–481
McIlwain CC, Townsend DM, Tew KD (2006) Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25(11):1639–1648
Meyer A (1996) Overview of enzymes of drug metabolism. J Pharmakokinet Pharmacodynam 24:449–459
Moyer AM, Salavaggione OE, Hebbrind SJ et al (2007) Glutathione S-transferase T1 and M1: gene sequence variation and functional genomics. Clin Cancer Res 13(23):2207–2216
Oken M, Creech R, Tormey D, Horton J, Davis T et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655
Omiecinski CJ, Vanden Heuvel JP, Perdew GH, Peters JM (2011) Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. Toxicol Sci 120(S1):S49–S75
Park SK, Yoo KY, Lee SJ et al (2000) Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Pharmacogenetics 10:301–309
Sarmanova J, Benesova K, Gut I et al (2001) Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin’s and non-Hodgkin’s lymphomas. Hum Mol Genet 10:1265–1273
Sheehan D, Meare G, Foley VM et al (2001) Structure, function and evolution of glutathione transferases: implication for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J 360:1–16
Skibola CF, Curry JD, Nieters A (2007) Genetic susceptibility to lymphoma. Haematologica 92:960–969
Soucek P, Sarmanova J, Nedelcheva-Kristensen V et al (2002) Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin’s and non-Hodgkin’s lymphomas. Int Arch Occup Environ Health 75(1):86–92
Vogl FD, Taioli E, Maugard C, Zheng W, Pinto LF, Ambrosone C, Parl FF, Nedelcheva-Kristensen V, Rebbeck TR, Brennan P, Boffetta P (2004) Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev 13(9):1473–1479
Conflict of interest
All authors declare that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abdel Rahman, H.A., Khorshied, M.M., Elazzamy, H.H. et al. The link between genetic polymorphism of glutathione-S-transferases, GSTM1, and GSTT1 and diffuse large B-cell lymphoma in Egypt. J Cancer Res Clin Oncol 138, 1363–1368 (2012). https://doi.org/10.1007/s00432-012-1208-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-012-1208-0